FcRγIIA attenuates pathology of cutaneous leishmaniasis and modulates ITAMa/i balance
2024

FcRγIIA and Its Role in Leishmaniasis

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ikram Hammi, Julien Giron-Michel, Myriam Riyad, Khadija Akarid, Damien Arnoult

Primary Institution: Hassan II University of Casablanca

Hypothesis

Does the Fc receptor FcγRIIA/CD32a play a role in the immune response to Leishmania infection?

Conclusion

The study suggests that FcγRIIA/CD32a may prevent tissue necrosis in cutaneous leishmaniasis and could be a potential therapeutic target.

Supporting Evidence

  • FcγRIIA/CD32a expression prevents tissue necrosis in infected mice.
  • Inflammation occurs earlier in CD32a Tg mice compared to wild-type mice.
  • Leishmania infection leads to a decrease in CD32a expression on macrophages.

Takeaway

This study looks at how a specific immune receptor helps protect against a disease caused by a parasite, showing it might be a good target for new treatments.

Methodology

The study used CD32a transgenic mice and wild-type mice infected with Leishmania major, along with in vitro experiments using THP-1 cells.

Potential Biases

Potential bias in the interpretation of results due to the use of specific strains of Leishmania.

Limitations

The study primarily focuses on mouse models, which may not fully replicate human responses.

Participant Demographics

Mice used were 6–8-week-old females with a C57BL/6 background.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s13071-024-06593-y

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication